Literature DB >> 28176486

Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome, and tyrosine-phosphatome in acute myeloid leukemia.

Jiefei Tong1,2, Mohamed Helmy3, Florence M G Cavalli2,4, Lily Jin1,2, Jonathan St-Germain5, Robert Karisch5, Paul Taylor1,2, Mark D Minden5, Michael D Taylor2,4,6, Benjamin G Neel5,7, Gary D Bader3,8, Michael F Moran1,2,8.   

Abstract

Reversible protein-tyrosine phosphorylation is catalyzed by the antagonistic actions of protein-tyrosine kinases (PTKs) and phosphatases (PTPs), and represents a major form of cell regulation. Acute myeloid leukemia (AML) is an aggressive hematological malignancy that results from the acquisition of multiple genetic alterations, which in some instances are associated with deregulated protein-phosphotyrosine (pY) mediated signaling networks. However, although individual PTKs and PTPs have been linked to AML and other malignancies, analysis of protein-pY networks as a function of activated PTKs and PTPs has not been done. In this study, MS was used to characterize AML proteomes, and phospho-proteome-subsets including pY proteins, PTKs, and PTPs. AML proteomes resolved into two groups related to high or low degrees of maturation according to French-American-British classification, and reflecting differential expression of cell surface antigens. AML pY proteomes reflect canonical, spatially organized signaling networks, unrelated to maturation, with heterogeneous expression of activated receptor and nonreceptor PTKs. We present the first integrated analysis of the pY-proteome, activated PTKs, and PTPs. Every PTP and most PTKs have both positive and negative associations with the pY-proteome. pY proteins resolve into groups with shared PTK and PTP correlations. These findings highlight the importance of pY turnover and the PTP phosphatome in shaping the pY-proteome in AML.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  AML; Kinome; PTPome; Proteome; pYome

Mesh:

Substances:

Year:  2017        PMID: 28176486      PMCID: PMC5500908          DOI: 10.1002/pmic.201600361

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  51 in total

1.  PTP1B targets the endosomal sorting machinery: dephosphorylation of regulatory sites on the endosomal sorting complex required for transport component STAM2.

Authors:  Matthew Stuible; Jasmine V Abella; Matthew Feldhammer; Misha Nossov; Veena Sangwan; Blagoy Blagoev; Morag Park; Michel L Tremblay
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

2.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

Authors:  John Rush; Albrecht Moritz; Kimberly A Lee; Ailan Guo; Valerie L Goss; Erik J Spek; Hui Zhang; Xiang-Ming Zha; Roberto D Polakiewicz; Michael J Comb
Journal:  Nat Biotechnol       Date:  2004-12-12       Impact factor: 54.908

Review 3.  PTP1B and TC-PTP: regulators of transformation and tumorigenesis.

Authors:  Matthew Stuible; Karen M Doody; Michel L Tremblay
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

4.  Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.

Authors:  Matthew Stuible; Liang Zhao; Isabelle Aubry; Dirk Schmidt-Arras; Frank-D Böhmer; Chao-Jun Li; Michel L Tremblay
Journal:  Chembiochem       Date:  2007-01-22       Impact factor: 3.164

5.  Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures.

Authors:  Yuhong Wei; Jiefei Tong; Paul Taylor; Dan Strumpf; Vladimir Ignatchenko; Nhu-An Pham; Naoki Yanagawa; Geoffrey Liu; Igor Jurisica; Frances A Shepherd; Ming-Sound Tsao; Thomas Kislinger; Michael F Moran
Journal:  J Proteome Res       Date:  2010-09-24       Impact factor: 4.466

6.  Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.

Authors:  Sooryanarayana Varambally; Jianjun Yu; Bharathi Laxman; Daniel R Rhodes; Rohit Mehra; Scott A Tomlins; Rajal B Shah; Uma Chandran; Federico A Monzon; Michael J Becich; John T Wei; Kenneth J Pienta; Debashis Ghosh; Mark A Rubin; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

7.  Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.

Authors:  Peter Paschka; Guido Marcucci; Amy S Ruppert; Krzysztof Mrózek; Hankui Chen; Rick A Kittles; Tamara Vukosavljevic; Danilo Perrotti; James W Vardiman; Andrew J Carroll; Jonathan E Kolitz; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

Review 8.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

Review 9.  The genetic architecture of multiple myeloma.

Authors:  Gareth J Morgan; Brian A Walker; Faith E Davies
Journal:  Nat Rev Cancer       Date:  2012-04-12       Impact factor: 60.716

10.  GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop.

Authors:  J Montojo; K Zuberi; H Rodriguez; F Kazi; G Wright; S L Donaldson; Q Morris; G D Bader
Journal:  Bioinformatics       Date:  2010-10-05       Impact factor: 6.937

View more
  7 in total

1.  Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines.

Authors:  Carolien van Alphen; Jacqueline Cloos; Robin Beekhof; David G J Cucchi; Sander R Piersma; Jaco C Knol; Alex A Henneman; Thang V Pham; Johan van Meerloo; Gert J Ossenkoppele; Henk M W Verheul; Jeroen J W M Janssen; Connie R Jimenez
Journal:  Mol Cell Proteomics       Date:  2020-02-26       Impact factor: 5.911

2.  Mechanosensing and Mechanoregulation of Endothelial Cell Functions.

Authors:  Yun Fang; David Wu; Konstantin G Birukov
Journal:  Compr Physiol       Date:  2019-03-15       Impact factor: 9.090

3.  Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap.

Authors:  Jüri Reimand; Ruth Isserlin; Veronique Voisin; Mike Kucera; Christian Tannus-Lopes; Asha Rostamianfar; Lina Wadi; Mona Meyer; Jeff Wong; Changjiang Xu; Daniele Merico; Gary D Bader
Journal:  Nat Protoc       Date:  2019-02       Impact factor: 13.491

Review 4.  Multimerin-1 and cancer: a review.

Authors:  Mareike G Posner
Journal:  Biosci Rep       Date:  2022-02-25       Impact factor: 3.840

5.  Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes.

Authors:  Shideh Mirhadi; Shirley Tam; Quan Li; Nadeem Moghal; Nhu-An Pham; Jiefei Tong; Brian J Golbourn; Jonathan R Krieger; Paul Taylor; Ming Li; Jessica Weiss; Sebastiao N Martins-Filho; Vibha Raghavan; Yasin Mamatjan; Aafaque A Khan; Michael Cabanero; Shingo Sakashita; Kugeng Huo; Sameer Agnihotri; Kota Ishizawa; Thomas K Waddell; Gelareh Zadeh; Kazuhiro Yasufuku; Geoffrey Liu; Frances A Shepherd; Michael F Moran; Ming-Sound Tsao
Journal:  Nat Commun       Date:  2022-04-05       Impact factor: 14.919

6.  Proteome and Phosphoproteome Changes Associated with Prognosis in Acute Myeloid Leukemia.

Authors:  Elise Aasebø; Frode S Berven; Sushma Bartaula-Brevik; Tomasz Stokowy; Randi Hovland; Marc Vaudel; Stein Ove Døskeland; Emmet McCormack; Tanveer S Batth; Jesper V Olsen; Øystein Bruserud; Frode Selheim; Maria Hernandez-Valladares
Journal:  Cancers (Basel)       Date:  2020-03-17       Impact factor: 6.639

Review 7.  The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives.

Authors:  Maria Hernandez-Valladares; Øystein Bruserud; Frode Selheim
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.